Physician

Adam Joseph Korzenko, M.D.

According to 2025 Medicare claims, Adam Korzenko, M.D. (NPI: 1538356308) practices dermatology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Suffolk, NY. This provider's primary affiliated billing organization is STONY BROOK DERMATOLOGY ASSOCIATES, UNIVERSITY FACULTY PRACTICE CORPOR (NPI: 1497700819; TIN: 113011790) and primary practice location at 11790-0989. Korzenko is affiliated with the Stony Brook ACO, LLC. (ACO ID: A4830), participating under the MSSP model.

Korzenko's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,749 traditional Medicare patients, billed 14,769 HCPCS/CPT codes, and received $922,296 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,104 prescription claims across 1,216 beneficiaries totaling $3,633,549 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 113 records totaling $2,795. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $502,370 to $922,296. Similarly, Part D prescription costs have moved sharply higher in recent years, from $519,189 to $3,633,549. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,643	9,795	$502,370
2016	1,804	11,362	$508,432
2017	1,914	11,482	$552,673
2018	1,962	11,447	$565,298
2019	2,205	12,497	$618,761
2020	1,927	9,905	$545,347
2021	2,187	11,243	$716,186
2022	2,414	11,574	$756,509
2023	2,616	13,909	$841,719
2024	2,749	14,769	$922,296

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	369	1,051	$519,189
2016	395	1,047	$611,015
2017	617	1,652	$746,973
2018	718	1,886	$872,346
2019	817	2,012	$812,514
2020	752	2,043	$1,056,627
2021	917	2,219	$1,427,841
2022	920	2,259	$1,655,026
2023	1,068	2,629	$2,289,366
2024	1,216	3,104	$3,633,549

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,341	1,968	$111
17110	Destruction of skin growth, 1-14 growths	614	698	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,624	2,300	$76
17000	Destruction of precancer skin growth, 1 growth	1,347	2,137	$46
17003	Destruction of precancer skin growth, 2-14 growths	896	3,626	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyrizi Pen	Risankizumab-Rzaa	53	4,100	$1,071,108
Dupixent Pen	Dupilumab	88	5,376	$718,824
Tremfya	Guselkumab	30	1,680	$409,897
Cosentyx Unoready Pen	Secukinumab	19	898	$272,877
Otezla	Apremilast	15	1,170	$178,412

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	113	$2,795	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Joseph Korzenko, M.D.?

Tedicare shows public-source Medicare data for Adam Joseph Korzenko, M.D. (NPI 1538356308), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Joseph Korzenko, M.D. have ACO affiliation data?

Adam Joseph Korzenko, M.D. is shown with ACO affiliation data for Stony Brook ACO, LLC. (MSSP, ACO ID A4830).

What billing organization is linked to Adam Joseph Korzenko, M.D.?

Adam Joseph Korzenko, M.D. is linked to STONY BROOK DERMATOLOGY ASSOCIATES, UNIVERSITY FACULTY PRACTICE CORPOR (billing NPI 1497700819) in the available physician profile data.

Does Adam Joseph Korzenko, M.D. have Open Payments data?

Adam Joseph Korzenko, M.D. has 113 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.